Regulatorische Updates
Regulatorische Entwicklungen von FDA, EMA, TGA und weltweit
#Patient Information Leaflet ×
Regulatorische Updates
23. Sept. 2026•1 Min. Lesezeit
B. Braun reports PIL errors in Meropenem 1000 mg infusion product
B. Braun Melsungen AG has informed the MHRA of patient information leaflet errors in certain Meropenem 1000 mg powder and solvent batches.
Regulatorische Updates
23. Aug. 2026•1 Min. Lesezeit
Omega Pharma Recalls Napralief 250mg Tablets Over Missing PIL Text
Omega Pharma Ltd is recalling specific batches of Napralief 250mg gastro‑resistant tablets because sections of the patient information leaflet and carton labeling are missing.
Regulatorische Updates
23. Aug. 2026•1 Min. Lesezeit
Milpharm Limited reports discrepancy in PIL for Loperamide 2 mg Orodispersible Tablets
Milpharm Limited has found a discrepancy in the approved Patient Information Leaflet for its 2 mg Loperamide hydrochloride orodispersible tablets.
Regulatorische Updates
23. Aug. 2026•1 Min. Lesezeit
Brancaster Pharma reports outdated PIL on notified batches
Brancaster Pharma informed the MHRA that cartons for the listed batches were supplied with an outdated Patient Information Leaflet.
Regulatorische Updates
23. Aug. 2026•1 Min. Lesezeit
Flamingo Pharma UK Ltd recalls Flucloxacillin 500mg capsules due to incorrect PIL
Flamingo Pharma UK Ltd notified the MHRA that some packs of Flucloxacillin Capsules BP 500 mg were supplied with the Patient Information Leaflet for Amoxicillin 500 mg, prompting a recall.